Assignee
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD
CN·13 granted patents·9 pending applications·0 citations·filing 2014–2023
Top patents by PatentIndex Score
22 records- 0167US2019216768A1Preparations of taxanes for intravenous administration and the preparation method thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 0259US2021179632A1Thienopiperidine derivative and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0357US2025304587A1Wee1 inhibitor, preparation therefor and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0456US12486259B2FXR agonist having pyrazine structure, and preparation method and useJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2020·Granted Dec 2, 2025·0 cites·11 claims
- 0556US2025034151A1Wee1 inhibitor, preparation therefor, and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0655US9714250B2Crystalline forms of temozolomide and the method for preparing sameJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 25, 2017·0 cites·9 claims
- 0753US2024199619A1Wee1 inhibitor and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0852US12559485B2CDK6/DYRK2 dual-target inhibitor, and preparation method therefor and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 24, 2026·0 cites·7 claims
- 0950US10745434B2Uridine phosphoramide prodrug, preparation method therefor, and medicinal uses thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 18, 2020·0 cites·5 claims
- 1049US2016200751A1Thienopiperidine derivative and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2014·Application pending·0 cites
- 1148US11130766B2Deuterated thienopiperidine derivatives, manufacturing method, and application thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 28, 2021·0 cites·4 claims
- 1246US10233202B2Tenofovir monobenzyl ester phosphamide prodrug, preparation method and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2016·Granted Mar 19, 2019·0 cites·20 claims
- 1345US11149016B2S-substituted-2-amino-3-mercaptopropionate derivative, preparation method and application thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 19, 2021·0 cites·8 claims
- 1445US2018338918A1Temsirolimus liposome and preparation method thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1543US10253007B2Taxanes compounds, preparation method therefor, and uses thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2014·Granted Apr 9, 2019·0 cites·14 claims
- 1643US9890175B2Taxane compound, and preparation method and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2014·Granted Feb 13, 2018·0 cites·11 claims
- 1740US2019070208A1Use of triacetyl-3-hydroxyphenyladenosine in preparing pharmaceuticals for treatment of atherosclerosisJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 1837US11058703B2Application of triacetyl-3-hydroxyphenyladenosine in preparation of pharmaceutical drug for preventing or treating non-alcoholic fatty liver diseaseJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 13, 2021·0 cites·9 claims
- 1937US2018153848A1Cabazitaxel fat emulsion, and preparation method and use thereofJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 2035US10005757B2Revaprazan hydrochloride polymorphs and preparation method thereforJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 26, 2018·0 cites·23 claims
- 2129US10358449B2Xanthine derivativeJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 23, 2019·0 cites·19 claims
- 2224US9981917B2Preparation method for revaprazan hydrochlorideJIANGSU TASLY DIYI PHARMACEUTICAL CO LTD·Filed 2015·Granted May 29, 2018·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →